Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philippe Rougier

Showing results (51-60 of 144) with videos related to

Pageof 15
Sort By:
Cancers|September 3, 2016
Imaging in Colorectal Cancer: Progress and Challenges for the CliniciansEric Van Cutsem, Henk M W Verheul, Patrik Flamen, et al.
World Journal of Gastroenterology|June 18, 2010
Autoimmune pancreatitis with atypical imaging findings that mimicked an endocrine tumorCindy Neuzillet, Céline Lepère, Mostafa El Hajjam, et al.
Endocrine-Related Cancer|December 13, 2006
Differentiated thyroid cancer cell invasion is regulated through epidermal growth factor receptor-dependent activation of matrix metalloproteinase (MMP)-2/gelatinase AMichael W Yeh, Jean-Philippe Rougier, Jin-Woo Park, et al.
Gastroenterologie Clinique Et Biologique|July 25, 2007
[The role of PET scan in gastrointestinal stromal tumors]Jean-Louis Alberini, Malik Al Nakib, Myriam Wartski, et al.
European Journal of Cancer (Oxford, England : 1990)|November 3, 2012
Quality of life analysis in patients with KRAS wild-type metastatic colorectal cancer treated first-line with cetuximab plus irinotecan, fluorouracil and leucovorinIstván Láng, Claus-Henning Köhne, Gunnar Folprecht, et al.
Anti-Cancer Drugs|June 19, 2004
Pharmacokinetic advantage of intra-arterial hepatic oxaliplatin administration: comparative results with cisplatin using a rabbit VX2 tumor modelRadan Dzodic, Gonzalo Gomez-Abuin, Philippe Rougier, et al.
World Journal of Gastroenterology|June 3, 2011
Neoadjuvant sorafenib combined with gemcitabine plus oxaliplatin in advanced hepatocellular carcinomaNicolas Williet, Olivier Dubreuil, Tarek Boussaha, et al.
Clinics and Research in Hepatology and Gastroenterology|February 25, 2014
Sustained response with gemcitabine plus Nab-paclitaxel after folfirinox failure in metastatic pancreatic cancer: report of an effective new strategyAlix Portal, Simon Pernot, Nathalie Siauve, et al.
Gastroenterologie Clinique Et Biologique|January 20, 2005
[Ovarian adenocarcinoma, primary or metastasic tumour of an adenocarcinoma of the colon: the role of molecular biology]Nicolas Goasguen, Catherine Julié, Jean-Nicolas Vaillant, et al.
European Journal of Cancer (Oxford, England : 1990)|May 7, 2013
Randomised, placebo-controlled, double-blind, parallel-group phase III study evaluating aflibercept in patients receiving first-line treatment with gemcitabine for metastatic pancreatic cancerPhilippe Rougier, Hanno Riess, Robert Manges, et al.
Pageof 15

Showing results (51-60 of 144) with videos related to

Sort By:
Pageof 15
Cancers|September 3, 2016
Imaging in Colorectal Cancer: Progress and Challenges for the CliniciansEric Van Cutsem, Henk M W Verheul, Patrik Flamen, et al.
World Journal of Gastroenterology|June 18, 2010
Autoimmune pancreatitis with atypical imaging findings that mimicked an endocrine tumorCindy Neuzillet, Céline Lepère, Mostafa El Hajjam, et al.
Endocrine-Related Cancer|December 13, 2006
Differentiated thyroid cancer cell invasion is regulated through epidermal growth factor receptor-dependent activation of matrix metalloproteinase (MMP)-2/gelatinase AMichael W Yeh, Jean-Philippe Rougier, Jin-Woo Park, et al.
Gastroenterologie Clinique Et Biologique|July 25, 2007
[The role of PET scan in gastrointestinal stromal tumors]Jean-Louis Alberini, Malik Al Nakib, Myriam Wartski, et al.
European Journal of Cancer (Oxford, England : 1990)|November 3, 2012
Quality of life analysis in patients with KRAS wild-type metastatic colorectal cancer treated first-line with cetuximab plus irinotecan, fluorouracil and leucovorinIstván Láng, Claus-Henning Köhne, Gunnar Folprecht, et al.
Anti-Cancer Drugs|June 19, 2004
Pharmacokinetic advantage of intra-arterial hepatic oxaliplatin administration: comparative results with cisplatin using a rabbit VX2 tumor modelRadan Dzodic, Gonzalo Gomez-Abuin, Philippe Rougier, et al.
World Journal of Gastroenterology|June 3, 2011
Neoadjuvant sorafenib combined with gemcitabine plus oxaliplatin in advanced hepatocellular carcinomaNicolas Williet, Olivier Dubreuil, Tarek Boussaha, et al.
Clinics and Research in Hepatology and Gastroenterology|February 25, 2014
Sustained response with gemcitabine plus Nab-paclitaxel after folfirinox failure in metastatic pancreatic cancer: report of an effective new strategyAlix Portal, Simon Pernot, Nathalie Siauve, et al.
Gastroenterologie Clinique Et Biologique|January 20, 2005
[Ovarian adenocarcinoma, primary or metastasic tumour of an adenocarcinoma of the colon: the role of molecular biology]Nicolas Goasguen, Catherine Julié, Jean-Nicolas Vaillant, et al.
European Journal of Cancer (Oxford, England : 1990)|May 7, 2013
Randomised, placebo-controlled, double-blind, parallel-group phase III study evaluating aflibercept in patients receiving first-line treatment with gemcitabine for metastatic pancreatic cancerPhilippe Rougier, Hanno Riess, Robert Manges, et al.
Pageof 15